These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 32272755)

  • 1. Mechanism of Secondary Ganglioside and Lipid Accumulation in Lysosomal Disease.
    Breiden B; Sandhoff K
    Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32272755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ganglioside GM2 catabolism is inhibited by storage compounds of mucopolysaccharidoses and by cationic amphiphilic drugs.
    Anheuser S; Breiden B; Sandhoff K
    Mol Genet Metab; 2019; 128(1-2):75-83. PubMed ID: 31097363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysosomal Glycosphingolipid Storage Diseases.
    Breiden B; Sandhoff K
    Annu Rev Biochem; 2019 Jun; 88():461-485. PubMed ID: 31220974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuronal Ganglioside and Glycosphingolipid (GSL) Metabolism and Disease : Cascades of Secondary Metabolic Errors Can Generate Complex Pathologies (in LSDs).
    Sandhoff R; Sandhoff K
    Adv Neurobiol; 2023; 29():333-390. PubMed ID: 36255681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gangliosides and gangliosidoses: principles of molecular and metabolic pathogenesis.
    Sandhoff K; Harzer K
    J Neurosci; 2013 Jun; 33(25):10195-208. PubMed ID: 23785136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Membrane lipids and their degradation compounds control GM2 catabolism at intralysosomal luminal vesicles.
    Anheuser S; Breiden B; Sandhoff K
    J Lipid Res; 2019 Jun; 60(6):1099-1111. PubMed ID: 30988135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endosomal/lysosomal processing of gangliosides affects neuronal cholesterol sequestration in Niemann-Pick disease type C.
    Zhou S; Davidson C; McGlynn R; Stephney G; Dobrenis K; Vanier MT; Walkley SU
    Am J Pathol; 2011 Aug; 179(2):890-902. PubMed ID: 21708114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secondary alterations of sphingolipid metabolism in lysosomal storage diseases.
    Prinetti A; Prioni S; Chiricozzi E; Schuchman EH; Chigorno V; Sonnino S
    Neurochem Res; 2011 Sep; 36(9):1654-68. PubMed ID: 21207141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuronal sphingolipidoses: Membrane lipids and sphingolipid activator proteins regulate lysosomal sphingolipid catabolism.
    Sandhoff K
    Biochimie; 2016 Nov; 130():146-151. PubMed ID: 27157270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secondary accumulation of gangliosides in lysosomal storage disorders.
    Walkley SU
    Semin Cell Dev Biol; 2004 Aug; 15(4):433-44. PubMed ID: 15207833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid changes in Niemann-Pick disease type C brain: personal experience and review of the literature.
    Vanier MT
    Neurochem Res; 1999 Apr; 24(4):481-9. PubMed ID: 10227680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential subcellular localization of cholesterol, gangliosides, and glycosaminoglycans in murine models of mucopolysaccharide storage disorders.
    McGlynn R; Dobrenis K; Walkley SU
    J Comp Neurol; 2004 Dec; 480(4):415-26. PubMed ID: 15558784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sphingolipids and neuronal degeneration in lysosomal storage disorders.
    Grassi S; Chiricozzi E; Mauri L; Sonnino S; Prinetti A
    J Neurochem; 2019 Mar; 148(5):600-611. PubMed ID: 29959861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Finding pathogenic commonalities between Niemann-Pick type C and other lysosomal storage disorders: Opportunities for shared therapeutic interventions.
    Yañez MJ; Marín T; Balboa E; Klein AD; Alvarez AR; Zanlungo S
    Biochim Biophys Acta Mol Basis Dis; 2020 Oct; 1866(10):165875. PubMed ID: 32522631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incorporation and metabolism of ganglioside GM2 in skin fibroblasts from normal and GM2 gangliosidosis subjects.
    Sonderfeld S; Conzelmann E; Schwarzmann G; Burg J; Hinrichs U; Sandhoff K
    Eur J Biochem; 1985 Jun; 149(2):247-55. PubMed ID: 3922757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progranulin associates with hexosaminidase A and ameliorates GM2 ganglioside accumulation and lysosomal storage in Tay-Sachs disease.
    Chen Y; Jian J; Hettinghouse A; Zhao X; Setchell KDR; Sun Y; Liu CJ
    J Mol Med (Berl); 2018 Dec; 96(12):1359-1373. PubMed ID: 30341570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurons in Niemann-Pick disease type C accumulate gangliosides as well as unesterified cholesterol and undergo dendritic and axonal alterations.
    Zervas M; Dobrenis K; Walkley SU
    J Neuropathol Exp Neurol; 2001 Jan; 60(1):49-64. PubMed ID: 11202175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. My journey into the world of sphingolipids and sphingolipidoses.
    Sandhoff K
    Proc Jpn Acad Ser B Phys Biol Sci; 2012; 88(10):554-82. PubMed ID: 23229750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lysosomal lipid storage diseases.
    Schulze H; Sandhoff K
    Cold Spring Harb Perspect Biol; 2011 Jun; 3(6):. PubMed ID: 21502308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ganglioside loading of cultured fibroblasts: a provocative method for the diagnosis of the GM2 gangliosidoses.
    Charrow J; Binns HJ
    Clin Chim Acta; 1986 Apr; 156(1):41-9. PubMed ID: 2938852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.